miR‐9 reduction resulted in increased expression of SASH1 and KRT13, already identified as miR‐9 targets in HNSCC cells (Citron et al,2017), and of the epithelial marker ZO‐1 (Fig 1B). Here, SASH1 is linked to head and neck squamous cell carcinoma.